66 related articles for article (PubMed ID: 35367599)
1. Drug Repurposing and DNA Damage in Cancer Treatment: Facts and Misconceptions.
Sertedaki E; Kotsinas A
Cells; 2020 May; 9(5):. PubMed ID: 32414147
[TBL] [Abstract][Full Text] [Related]
2. PharmGKB summary: disulfiram pathway.
Gonzalez-Suarez AD; Thorn CF; Whirl-Carrillo M; Klein TE
Pharmacogenet Genomics; 2023 Dec; 33(9):207-216. PubMed ID: 37728645
[No Abstract] [Full Text] [Related]
3. Disulfiram ameliorates nonalcoholic steatohepatitis by modulating the gut microbiota and bile acid metabolism.
Lei Y; Tang L; Chen Q; Wu L; He W; Tu D; Wang S; Chen Y; Liu S; Xie Z; Wei H; Yang S; Tang B
Nat Commun; 2022 Nov; 13(1):6862. PubMed ID: 36369291
[TBL] [Abstract][Full Text] [Related]
4. Applications and Opportunities in Using Disulfides, Thiosulfinates, and Thiosulfonates as Antibacterials.
Blume L; Long TE; Turos E
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240003
[TBL] [Abstract][Full Text] [Related]
5. Disulfiram: Mechanisms, Applications, and Challenges.
Lanz J; Biniaz-Harris N; Kuvaldina M; Jain S; Lewis K; Fallon BA
Antibiotics (Basel); 2023 Mar; 12(3):. PubMed ID: 36978391
[No Abstract] [Full Text] [Related]
6. Repurposing Disulfiram as an Antimicrobial Agent in Topical Infections.
Lajarin-Reinares M; Pena-Rodríguez E; Cañellas-Santos M; Rosell-Vives E; Cortés P; Casas ML; Calvo MÀ; Fernandez-Campos F
Antibiotics (Basel); 2022 Dec; 11(12):. PubMed ID: 36551409
[TBL] [Abstract][Full Text] [Related]
7. Recent Advances in Antabuse (Disulfiram): The Importance of its Metal-binding Ability to its Anticancer Activity.
Viola-Rhenals M; Patel KR; Jaimes-Santamaria L; Wu G; Liu J; Dou QP
Curr Med Chem; 2018 Feb; 25(4):506-524. PubMed ID: 29065820
[TBL] [Abstract][Full Text] [Related]
8. Repurposing Disulfiram as An Anti-Cancer Agent: Updated Review on Literature and Patents.
Ekinci E; Rohondia S; Khan R; Dou QP
Recent Pat Anticancer Drug Discov; 2019; 14(2):113-132. PubMed ID: 31084595
[TBL] [Abstract][Full Text] [Related]
9. Repurposing disulfiram for treatment of Staphylococcus aureus infections.
Thakare R; Shukla M; Kaul G; Dasgupta A; Chopra S
Int J Antimicrob Agents; 2019 Jun; 53(6):709-715. PubMed ID: 30954635
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial activity of disulfiram and its metabolites.
Frazier KR; Moore JA; Long TE
J Appl Microbiol; 2019 Jan; 126(1):79-86. PubMed ID: 30160334
[TBL] [Abstract][Full Text] [Related]
11. Repositioning of non-antibiotic drugs as an alternative to microbial resistance: a systematic review.
Foletto VS; da Rosa TF; Serafin MB; Bottega A; Hörner R
Int J Antimicrob Agents; 2021 Sep; 58(3):106380. PubMed ID: 34166776
[TBL] [Abstract][Full Text] [Related]
12. Repurposing disulfiram to target infections caused by non-tuberculous mycobacteria.
Das S; Garg T; Chopra S; Dasgupta A
J Antimicrob Chemother; 2019 May; 74(5):1317-1322. PubMed ID: 30753528
[TBL] [Abstract][Full Text] [Related]
13. Repurposing Thiram and Disulfiram as Antibacterial Agents for Multidrug-Resistant Staphylococcus aureus Infections.
Long TE
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674046
[TBL] [Abstract][Full Text] [Related]
14. Systematic review of disulfiram as an antibacterial agent: what is the evidence?
Meneguello JE; Murase LS; de Souza JVP; de Oliveira CG; Ghiraldi-Lopes LD; Teixeira JJV; Scodro RBL; Ferracioli KRC; Siqueira VLD; Campanerut-Sá PAZ; Cardoso RF
Int J Antimicrob Agents; 2022 May; 59(5):106578. PubMed ID: 35367599
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
